Search - tctmd.com

Displaying 521 - 540 of 786

Sort: Relevancy | Date

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

News Industry News

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

May 22, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation EuroPCR 2014

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Presenter: Hiroyoshi Yokoi

May 21, 2014

News Industry News

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

May 21, 2014

News Industry News

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

May 21, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Industry News

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

May 21, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

Yael L. Maxwell

May 21, 2014

News Industry News

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

May 21, 2014

News Industry News

Boston Scientific Reports Strong Performance Data For SYNERGY™ Stent System

May 21, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

Presentation EuroPCR 2014

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Presenter: Jos? Ram?n L?pez-M?nguez

May 20, 2014

Presentation EuroPCR 2014

Primary Results of the Multicenter COBRA Trial

Presenter: Christophe Dubois

May 20, 2014

Presentation EuroPCR 2014

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

Presenter: Josep Rod?s-Cabau

May 20, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

News Industry News

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

May 20, 2014

Advertisement

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Post‐Market Surveillance Study of Paclitaxel‐Eluting Nitinol Stents for Treating FemoropoplitealArtery Disease in Japan: 12‐Month Results

Successful Live Case Demonstration of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System at EuroPCR

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

EuroPCR Features PAD Therapies in Early Development and Real-World Use

EUROMAX Subanalysis: Bivalirudin Bests Heparin Regardless of GPI Use in STEMI

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

Boston Scientific Reports Strong Performance Data For SYNERGY™ Stent System

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

BABILON TRIAL: A prospective randomized study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions

Primary Results of the Multicenter COBRA Trial

Left Atrial Decompression Through Unidirectional Left-to-Right Shunt for the Treatment of Left Cardiac Failure: Initial Experience with the V-Wave Device

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Medtronic Announces CE Mark and Launch of NC Euphora(TM) Coronary Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content